{
  "name" : "dacemirror.sci-hub.se_journal-article_fe94228ddd23ed1f21bf2e22b401cae3_wang2019.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "The Nano–Bio Interactions of Nanomedicines: Understanding the Biochemical Driving Forces and Redox Reactions",
    "authors" : [ "Yaling Wang", "Rong Cai", "Chunying Chen" ],
    "emails" : [ ],
    "sections" : [ {
      "heading" : "The Nano−Bio Interactions of Nanomedicines: Understanding the Biochemical Driving Forces and Redox Reactions",
      "text" : "Published as part of the Accounts of Chemical Research special issue “Nanomedicine and Beyond”."
    }, {
      "heading" : "Yaling Wang,† Rong Cai,† and Chunying Chen*,†,‡",
      "text" : "†CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China ‡University of Chinese Academy of Sciences, Beijing 100049, China\nCONSPECTUS: Engineered nanomaterials (ENMs) have been developed for imaging, drug delivery, diagnosis, and clinical therapeutic purposes because of their outstanding physicochemical characteristics. However, the function and ultimate efficiency of nanomedicines remain unsatisfactory for clinical application, mainly because of our insufficient understanding of nanomaterial/nanomedicine−biology (nano−bio) interactions. The nonequilibrated, complex, and heterogeneous nature of the biological milieu inevitably influences the dynamic bioidentity of nanoformulations at each site (i.e., the interfaces at different biological fluids (biofluids), environments, or biological structures) of nano−bio interactions. The continuous interplay between a nanomedicine and the biological molecules and structures in the biological environments can, for example, affect cellular uptake or completely alter the designed function of the nanomedicine. Accordingly, the weak and strong driving forces at the nano−bio interface may elicit structural reconformation, decrease bioactivity, and induce dysfunction of the nanomaterial and/or redox reactions with biological molecules, all of which may elicit unintended and unexpected biological outcomes. In contrast, these driving forces also can be manipulated to mitigate the toxicity of ENMs or improve the targeting abilities of ENMs. Therefore, a comprehensive understanding of the underlying mechanisms of nano−bio interactions is paramount for the intelligent design of safe and effective nanomedicines. In this Account, we summarize our recent progress in probing the nano−bio interaction of nanomedicines, focusing on the driving force and redox reaction at the nano−bio interface, which have been recognized as the main factors that regulate the functions and toxicities of nanomedicines. First, we provide insight into the driving force that shapes the boundary of different nano−bio interfaces (including proteins, cell membranes, and biofluids), for instance, hydrophobic, electrostatic, hydrogen bond, molecular recognition, metal-coordinate, and stereoselective interactions that influence the different nano−bio interactions at each contact site in the biological environment. The physicochemical properties of both the nanoparticle and the biomolecule are varied, causing structure recombination, dysfunction, and bioactivity loss of proteins; correspondingly, the surface properties, biological functions, intracellular uptake pathways, and fate of ENMs are also influenced. Second, with the help of these driving forces, four kinds of redox interactions with reactive oxygen species (ROS), antioxidant, sorbate, and the prosthetic group of oxidoreductases are utilized to regulate the intracellular redox equilibrium and construct synergetic nanomedicines for combating bacteria and cancers. Three kinds of electron-transfer mechanisms are involved in designing nanomedicines, including direct electron injection, sorbate-mediated, and irradiation-induced processes. Finally, we discuss the factors that influence the nano−bio interactions and propose corresponding strategies to manipulate the nano−bio interactions for advancing nanomedicine design. We expect our efforts in understanding the nano−bio interaction and the future development of this field will bring nanomedicine to human use more quickly."
    }, {
      "heading" : "1. INTRODUCTION",
      "text" : "Engineered nanomaterials (ENMs) can be exploited as carriers to deliver traditional drugs to desired biological targets or can serve as drugs themselves with high efficiency and specificity. Numerous judicious strategies have been proposed for the intracellular delivery of ENMs, and clinical evaluations have already been initiated. However, the final targeting efficiency (typically less than 1%) is far from satisfactory, and clinical use in patients is rare.1 The remnant ENMs that do not reach the intended target sites may provoke biological side effects in\nvivo, such as inflammatory responses, oxidative stress, direct\ntoxicity, and so on. These drawbacks raise concerns about the\noverall safety of nanomedicine, contributing to the large gap\nbetween the development of novel nanomedicines and clinical\ntranslation. This disparity is mainly attributed to an insufficient\nunderstanding of the dynamic2 and varied interactions between\nReceived: March 8, 2019 Published: May 31, 2019\nArticle\npubs.acs.org/accountsCite This: Acc. Chem. Res. 2019, 52, 1507−1518\n© 2019 American Chemical Society 1507 DOI: 10.1021/acs.accounts.9b00126 Acc. Chem. Res. 2019, 52, 1507−1518\nD ow\nnl oa\nde d\nvi a\nU N\nIV O\nF SO\nU T\nH E\nR N\nI N\nD IA\nN A\no n\nJu ly\n1 8,\n2 01\n9 at\n1 4:\n14 :0\n4 (U\nT C ). Se e ht tp s: //p ub s. ac s. or g/ sh ar in gg ui de lin es f or o pt io ns o n ho w to le gi tim at el y sh ar e pu bl is he d\nar tic\nle s.\nnanomedicines and the complex and heterogeneous biological microenvironment (“nano−bio” interactions).3 The nano−bio interaction occurs at the interface of the ENM surface and the surrounding biological fluids (biofluids) or biostructures.4 The kinetic and thermodynamic physicochemical interactions at the nano−bio interface inevitably influence the pristine bioidentity of ENMs,5 eliciting various kinds of cellular and biological responses, which are increasingly becoming accepted as the main factors determining the targeting efficiency and biological outcome of a nanomedicine. The important and active interactions of ENMs with the surrounding medium are (i) adsorption of biomolecules in the medium, (ii) dissolution, (iii) surface reconstruction to minimize free energy, and (iv) redox reactions with contact components at the ENM surface. For example, the formation of a bimolecular-corona at the outer surface of a nanoparticle (NP) in biofluids may activate different cell signaling pathways, subsequently resulting in very different in vivo pharmaceutical routes and toxicological behaviors compared to the pristine nanomedicine.6,7 The exchange of surface ligands of gold nanoparticles (AuNPs) with the cell membrane lipid bilayer can affect the endocytosis pathway and uptake efficiency.8 Dissolution of ZnO nanoparticles to form zinc ions and the release of reactive oxygen species (ROS) by ZnO nanoparticles can induce endoplasmic reticulum (ER) stress and toxicity to human umbilical vein endothelial cells (HUVECs).9 We found that this toxicity can be diminished by preforming a corona at the ZnO surface.10 These toxicological phenomena have also been observed with some Ag nanoparticles (AgNPs). The ability of AgNPs to generate ROS generation is beneficial in combating bacterial infection.11\nWhether the targeted cell (i.e., the cancer cells) or the nontargeted cell (i.e., the normal cells) are killed by ENMs is decided by the “power” that governs the nano−bio interactions. The interactions occurring at the nano−bio interface are influenced by physicochemical properties of ENMs, the components in surrounding medium, and the biological parameters at the contact zones.12 Identifying the underlying principles that determine the nano−bio interactions and quantifying the relationship between characteristic physicochemical properties are greatly important to designing the desired biological functions and outcomes of a nanomedicine. This Account highlights the contributions of our group to the understanding of the nano−bio interaction. We have examined the driving forces and redox interactions, with respect to the cell, and utilized nano−bio interactions to design nanomedicines for cancer therapy and combating microorganisms."
    }, {
      "heading" : "2. MAIN DRIVING FORCES AT THE NANO−BIO INTERFACE DETERMINE THE BIOLOGICAL FEATURES OF NANOMEDICINES",
      "text" : "Rapidly accumulating evidence indicates that ENMs inevitably interact with biological systems, including biofluids, biomolecules (proteins, DNA/RNAs, lipids, etc.), and cell membranes, producing a nano−bio interface that is influenced by several biophysicochemical interactions (Figure 1). Fundamentally, the interactions between ENMs and the surrounding biomolecules are mainly determined by noncovalent interactions, including van der Waals forces, electrostatic interactions, hydrophobic interactions, and hydrogen bonding. Some relatively strong interactions, including ligand−receptor\ninteraction, stereoselective interaction, and metal−ligand coordination, increase the complexity of nano−bio interactions. These nano−bio interactions are key steps in the function and fate of nanomedicines, influencing the dynamic bioidentity of ENMs and the consequent biological outcomes."
    }, {
      "heading" : "2.1. Nano−Protein Interface",
      "text" : "The nano−protein interface is the most important interface because of the huge amount of proteins, each having specific biological functions affecting the biological function and fate of NPs in vivo. At the nano−protein interface, the dominating driving forces are electrostatic interaction, hydrophobic interaction, hydrogen bonding, and stereoselectivity. The role of each driving force is dependent on charge, amino acid sequence distribution, size and structure of protein, and physiochemical properties of NPs, particularly including hydrophobicity, surface charge of NPs, and molecular structure of the nanointerface. The interaction site, direction, rate, duration, and stability of protein on the surfaces of NPs are also influenced by the temperature, pH, and ion strength of the surrounding fluids.5\n2.1.1. Hydrophobic Interaction. Hydrophobic carbonbased ENMs, such as single-wall carbon nanotubes (SWCNTs), greatly depend on the number of hydrophobic amino acid residues in the proteins. The π−π stacking interactions between SWCNTs and hydrophobic proteins are the driving forces for serum protein binding onto the surface of SWCNTs (Figure 2A).13 The π-cation interactions and/or π−π-cation interactions have also emerged as driving forces13 that might be underappreciated and in need of investigation. We also found that AgNPs interact with human serum albumin predominantly via hydrophobic forces.14 The hydrophobic interactions with NPs also depend on their shape. An increasing overlap of the hydrophobic regions of the interacting nanoparticle surfaces results in a higher contribution of the hydrophobic interactions in the sequence nanorods < nanobipyramids < nanospheres < nanocubes.15\n2.1.2. Electrostatic Interaction. The electrostatic forces govern the interaction between positively charged ZnO NPs and negatively charged BSA.10 The concentrations and types of amino acids distributed at the nano−protein interfaces are\nDOI: 10.1021/acs.accounts.9b00126 Acc. Chem. Res. 2019, 52, 1507−1518\n1508\nimportant to the adsorption of protein on the NPs. We demonstrated that the amino acid residue distribution at the side face of transferrin (Tf, a widely used protein for cancer targeting) influenced the interactions with penicillamine-AuNP (Pen-AuNP) and also determined the carried charge of the Pen-AuNP−Tf complex.16 Subsequently, Pen-AuNP−Tf complexes attached onto the lipid bilayer driven by electrostatic force as well. At the nano−protein interface, hydrogen bonding acts in combination with electrostatic forces, leading to the formation of strong salt bridges, which behave like specific interactions at the BSA and Pen-AuNP chiral surfaces (Figure 2B).17 Because of the effects of amino acid sequences in protein charge distribution, the NPs may have sequence\nspecificity for protein or polypeptide binding that may provide a new strategy for targeting nanomedicines.\n2.1.3. Molecular Recognition. To improve the drug accumulation in the disease site, targeting ligands are indispensable for development of nanomedicines. Molecular recognition, including the interactions between ligands and their cognate receptors, antigens and antibodies, and substrates and enzymes, are the most widely used for targeting and specific recognition. Hyaluronic acid-modified NPs exhibit a specific binding to the CD44 on the cell membrane, such as on MDA-MB-231 cells, leading to increased NP internalization.18\nThe binding affinity of antigens to antibodies is also exploited in nanomedicine. In different electrolyte environments, changes in the antigen−antibody binding force are explained\nDOI: 10.1021/acs.accounts.9b00126 Acc. Chem. Res. 2019, 52, 1507−1518\n1509\nby the polyelectrolyte effect and hydrophobic interactions.19 Stereoselectivity is also important to the nano−bio interface interaction, which depends on the molecular structure of the nanomedicine. Phenylalanine-modified nanoceria were optimal for the 3,4-dihydroxyphenylalanine oxidation reaction and showed excellent stereoselectivity toward its enantiomers.20 We demonstrated that the native steric conformation of proteins contributes to a stereoselective interaction between a chiral NP surface and proteins, resulting in a specific adsorption orientation of proteins on the NP surface (Figure 2C).16 The chiral NP surface determines the orientation and conformation of transferrin, which subsequently affects the interaction and recognition of transferrin with its receptor on the cell membrane. 2.1.4. Metal−Ligand Coordination. In addition to the aforementioned weak interactions, the coordination of metal atoms to ligand atoms is also important to the nano−bio interface. For example, the high electronegative atoms of the protein and other biomolecules have high affinity to the surface of metal nanoparticles (like AuNPs and AgNPs). By using Xray absorption near edge structure spectroscopy (XANES), we have investigated the interaction between gold nanorods (GNRs) and BSA to find that the BSA sulfur species changed from S−S to Au−S, suggesting that the final interaction of BSA with GNRs is Au−S coordination even though the initial interaction was electrostatic in nature (Figure 2D).7 Crystalline nano-Ag2S also has been detected at the surface of silver NPs in cell culture medium.2 Metallothionein is involved in the degradation of AgNPs and the transport of Ag ions. Rare-earth oxide nanoparticles (e.g., Gd2O3 and La2O3) capture structural phosphates from cell membranes and proteins.21 Interestingly, we developed a radiosensitizer, poly(vinylpyrollidone)- and selenocysteine-modifed Bi2Se3 nanoparticles (PVP Bi2Se3@Sec NPs), that can be incorporated into proteins in vivo via the amino acid selenocysteine (Sec), which can be used to form selenoproteins though reduction and methylation reactions.22 On the other hand, adsorbed proteins impact the physicochemical properties of NPs and can lead to their degradation. It has also been found that the interaction of metal oxide NPs with serum proteins increases their dissolution rates.2,3"
    }, {
      "heading" : "2.2. Nano−Membrane Interface",
      "text" : "2.2.1. Electrostatic Interaction. Cell membranes are mainly composed of proteins and self-assembled lipids bilayer and are generally considered as negatively charged. The electrostatic forces, hydrophobic interaction, and hydrogen bond are the main driving forces for charged NPs contacting the cell membrane. In general, the positively charged NPs are attracted stably by the negatively charged glycocalyx and remained in situ for long enough, which eventually entered into the cells by endocytosis.23 This strategy is widely used for enhancing the internalization of NPs. AuNPs modified with ssDNA (AuNP-S-T8(−) and AuNP-S-T18(−)) were observed to interact with positively charged bilayers (Figure 2E).8 The electrostatic repulsion is also important for the interaction between nanoparticle ligands and the cell membrane interface. The succession of repulsive-sedimentary interactions between the negative particle and the negatively charged glycocalyx found on the cell membrane surface induces cell junction targeting and endothelial leakiness.24\n2.2.2. Membrane Curvature. The interaction between NPs and biological membranes is also mediated by the\nmembrane curvature.25 The biological membranes are often highly curved; the initial curvature of the membrane drives the adsorption behavior of Janus particles. When the Janus particle adsorbed inside the membranes, the curvature-mediated interactions are repulsive. This finding helps us understand the way NPs are wrapped by cell membranes prior to internalization. In addition to the driving forces and local curvature, the receptors’ and rafts’ distribution, mobility, heterogeneity, and stiffness of the cell membranes are important for nano−bio interactions."
    }, {
      "heading" : "2.3. Nano−Biofluid Interface",
      "text" : "The ubiquitous biofluids are vital for life activities; they contain water, dissolved small molecules (O2, H2O2, etc.), and ions and mediate the energy and substance exchanges. The nano− biofluids interface interaction is a neglected one among all nano−bio interfaces. The role of H2O and O2 molecules in biofluids regulating the feature of nanomedicine requires more attention. Hydrogen bonding is the main driving force at the nano−biofluid interface. We found that NaGdF4 NPs capped by poly(acrylic acid) (PAA) show superior relaxivity for better bioimaging than those capped by polyethylenimine (PEI) and polyethylene glycol (PEG), which is attributed to the strong hydrogen-bond formation between PAA and water molecules (Figure 2F).27 Interestingly, the O2 molecule in biofluids on the [730] facet of Pd nanocrystals forms stronger hydrogen bonds with the hydroxyl terminal of ascorbate than that on the [100] facet,28 serving more efficiently as a precursor for the subsequent oxidation reaction of ascorbate. Besides that, the flow velocity,29 viscosity, stiffness, and diffusivity30 of the biofluids can also influence the transportation and interaction of nanomedicines in vivo. All these reports suggest the nano− biofluid interface interactions are in urgent need of study and can be utilized for improving the relevant biological effects of NPs. Because most nano−bio interfaces are mediated by more than one type of driving force, it is necessary to establish an index of reactions for evaluating the nano−bio interface. At the nano−bio interface, electrostatic interaction, hydrogen bonding, hydrophobic interaction, and stereoselectivity are the main driving forces, while the metal−ligand coordination and van der Waals (VDW) forces31 and biofluids mechanics also play important roles in the fate and behavior of nanomedicines. The dominating driving force is significantly correlated with physicochemical properties of the nanomedicine. These nano−bio interactions determine the biological fate of nanomedicines, such as protein corona formation, blood circulation time, interaction with the reticuloendothelial system, targeting desired sites, particle wrapping at cell surfaces, cellular internalization, biodistribution, intracellular functionalization, biocatalysis, and interaction with DNA. Hence, evaluating the mechanisms underlying the nano−bio interface enables us to develop safe nanomedicines based on fundamental features of biological systems."
    }, {
      "heading" : "3. CHEMICAL REDOX REACTIONS INFLUENCE THE",
      "text" : "NANO−BIO INTERACTION\nNumerous driving forces play important roles in determining the dynamic bioidentity of ENMs, guiding the ENMs into the cell and promoting chemical redox reactions between the ENMs and the redox species inside the cell. Reactive oxygen and nitrogen species (ROS and RNS, respectively) are critical to the maintenance of cellular redox equilibrium, cell survival,\nDOI: 10.1021/acs.accounts.9b00126 Acc. Chem. Res. 2019, 52, 1507−1518\n1510\nmetabolism, intracellular signaling cascades, and innate immunity regulation. Intracellular ROS/RNS, including O2\n•−, H2O2, ·OH, 1O2 (singlet oxygen), HO2 •, NO, and ONOO−, all of which have chemical reactivity higher than that of molecular oxygen, can react with lipids, proteins, and genetic materials,32\neventually eliciting a series of downstream, biological events. As shown in Figure 3, ROS is generated via the mitochondrial respiratory chain and is regulated by intracellular oxidoreductases (e.g., superoxide dismutase [SOD], catalase33), small molecular antioxidants, and so on. When some external stimuli\nexist, including irradiation by UV light, γ- or X-rays, smoking, air pollution, or pathological conditions (hypoxia or inflammation), the balance of producing and scavenging ROS/RNS can become disturbed. Aberrant accumulation of intracellular ROS/RNS, dysfunction of key ROS/RNS detoxifying enzymes, or an insufficient level of antioxidants can initiate a multitiered cascade of oxidative stress,34 which stimulates the antioxidant defense, inflammatory response, cytotoxicity, and cell death. ENMs and/or other nanomedicines can interact with these redox-related biological species by generating and\nDOI: 10.1021/acs.accounts.9b00126 Acc. Chem. Res. 2019, 52, 1507−1518\n1511\nscavenging ROS/RNS, which influence the redox equilibrium and the fate of the cell. As shown in Figure 4A, oxygen is converted into water through four single electron-transfer steps. This process involves O2\n•−, H2O2, and ·OH; the latter reactive species can be rapidly detoxified by an endogenous oxidoreductase (SOD/ reductase,35 CAT, peroxidase [POD], cytochrome C [Cyt C] oxidase, etc.) with the help of some small molecular antioxidants (reduced glutathione21) under normal conditions. Neutral molecular oxygen (O2) and H2O2 can readily cross cell membranes to play significant roles in the biological radical generation process. Smart nanomedicine systems are designed to target the sites of disease, either (1) to serve as pro-oxidants, producing ROS/ RNS or blocking the detoxification of ROS/RNS, or inducing cell death of cancer/microorganisms or (2) to serve as antioxidants via scavenging ROS/RNS or supplying oxygen to mitigate hypoxic conditions. Importantly, the excess nanomedicine circulating to normal cells may also have the potential to elicit toxicity in the normal cells. ENMs may function as ROS/RNS pro-oxidants or antioxidants via four different redox interaction routes (Figure 4B): (i) direct interaction with reactive radical species36 to scavenge ROS/ RNS or supply molecular oxygen, mitigating the oxidative stress or hypoxia; (ii) reaction with neutral free molecules, such as O2, H2O2, and H2O, to generate ROS/RNS; (iii) direct interaction with the highly electronegative atoms of antioxidant biomolecules (e.g., GSH);37 (iv) interaction with the key prosthetic group of an oxidoreductase involved in ROS/RNS detoxification (Figure 4A) or generation, which may thus limit enzyme activity. For example, we found that graphene can\ndecrease mitochondrial electron-transfer chain activity,38 thus diminishing ROS/RNS production, and thereby inhibiting the migration and invasion of cancer cells."
    }, {
      "heading" : "3.1. Mechanism of Electron Transfer in Redox Interactions at the Nano−Bio Interface",
      "text" : "The ROS/RNS-generating or -scavenging capacity of ENMs is one of the key characteristics impacting the efficacy and safety of a nanomedicine in humans. To predict the ROS/RNS generation ability of an ENM, redox potential (normal hydrogen electrode scale,39 aqueous redox couples) or energy levels of conduction band (CB) and valence band (VB) (absolute vacuum scale [AVS]) were introduced to predict the thermodynamic likelihood of redox reactions between ENMs and the surrounding biospecies.40,41 In 2010, Burello and Worth theoretically predicted that some metal oxide nanoparticles (∼20−30 nm) possess CB energies comparable to the redox potentials of some active redox couples, suggesting the NPs could cause oxidative stress and toxicity.41 This possibility was experimentally proven, showing that CB energy levels of six kinds of metal oxide nanoparticles located in the cellular redox potential range elicit oxidative stress and inflammation.40 At the same time, the dissolution and degradation of surface atoms also contribute to the cytotoxicity.9\nElectron-transfer processes will occur between ENMs and soluble species in the cell only if the relevant orbital energies of the electron donors and acceptors are approximately at the same level.42 Three main mechanisms are involved in nano− bio interfacial electron-transfer processes: (i) direct electron injection, (ii) surface sorbate (protein, photosensitizer)mediated electron transfer, and (iii) irradiation-induced electron transfer.\nDOI: 10.1021/acs.accounts.9b00126 Acc. Chem. Res. 2019, 52, 1507−1518\n1512\n3.1.1. Direct Electron Injection. When the redox potentials of reactive species in biological medium are higher than the energy levels of ENMs, electrons can directly transfer to the ENMs, enabling the ENMs to scavenge ROS/RNS. We have investigated some carbon ENMs, including carbon nanotubes, fullerene and its derivatives, graphene and its derivatives, and Pd nanoparticles, that have ROS-scavenging abilities.36,43 The fullerene derivatives can directly react with ROS (Figure 5A). Cubic and octahedral Pd nanoparticles (Figure 5B) can perform similarly to CAT and SOD, reacting with O2\n•− and H2O2 to generate O2; decrease lipid, protein ,and DNA damage caused by oxidative stress; and decrease apoptosis (Figure 5C−E).43 3.1.2. Surface Sorbate-Mediated Electron Transfer. Some pristine ENMs cannot react with or produce redox species. However, the surface sorbate obtained via interaction with biological components, such as O2, H2O2, oxidoreductases (e.g., SOD), and thiol-containing molecules (e.g., GSH), change the surface energy properties of ENMs, enabling surface atom dissolution or electron donation, reducing O2, H2O2, or H2O to form O2\n•− or ·OH (Figure 6A).44 We have found that Pd nanocubes and octahedrons generate ·OH under\nacidic conditions via surface-adsorbed H2O2 (Figure 6B). These surface-modified nanocubes exhibit antibacterial activity against S. aureus and E. coli.45 The survival rates of bacteria are dramatically decreased with increasing Pd concentrations, while the morphology of bacteria treated with Pd nanoparticles is affected (Figure 6C,D), becoming uneven with a wrinkling of the cell membrane. We also found that, after surface coating with CuZn-SOD or RuN3, Nanoceria larger than 5 nm can obtain extra electrons from the coating sorbate to activate the particle’s activity as a superoxide scavenger.44 Similarly, a low concentration of AgNPs interact with thiol-containing molecules, promoting the degradation or dissolution of AgNPs to elicit ROS formation and subsequent oxidative stress and apoptosis in several cell types.11\n3.1.3. Irradiation-Induced Electron-Transfer Processes. Several semiconductive ENMs possess filled VBs and empty CBs. When the conduction band energy of ENMs is too high, direct electron transfer to cell redox species is unfavorable.42 However, if the ENMs absorb the appropriate energy via irradiation (e.g., UV light, X-ray), when Ehν ≥ Ebg, an electron (e−) of the VB is excited to the CB, and a corresponding hole (h+) is generated at the VB.46 As shown in\nDOI: 10.1021/acs.accounts.9b00126 Acc. Chem. Res. 2019, 52, 1507−1518\n1513\nFigure 7A, the photogenerated electrons can fall back to the hole (recombination ①) or transfer to an acceptor (sorbate, ② photoreduction) or photosensitizer (④) on the ENMs or in the solution to generate the ROS. Meanwhile, the photogenerated holes, which have high electron affinity and oxidizing ability, can accept the electron from the adsorbed electron donor (③ photooxidation). These photoinduced physical and chemical properties of\nENMs enable us to design smart nanomedicines. For example, we have constructed hollow carbon nanospheres (HCSs; Figure 7B), which possess a hollow inner space that can carry the drug doxorubicin (DOX). After the HCSs enter lysosomes and are irradiated with a near-infrared laser, the DOX is released. The subsequent elevated cellular ROS stimulates the expression of heat shock factor-1 protein homotrimers.\nThrough this mechanism, the activation and function of drug resistance-related genes is suppressed to decrease the resistance of human breast cancer cells (MCF-7/ADR) to DOX (Figure 7C−F).47"
    }, {
      "heading" : "3.2. Effects of the Physicochemical Properties of ENMs and the Microenvironment on the Redox Processes",
      "text" : "Electron transfer at the nano−bio interface is a complicated process constrained by a variety of factors. When the energy levels of ENMs are close to intracellular redox couples (Figure 8A), active atoms in ENMs perform the redox reaction, resulting in the dissolution of surface atoms or the adsorption of biomolecules, until the chemical potentials of the ENM surface atom electrons and biomolecules are equalized. The redox potentials and energy states of the surface atoms differ with the varying size, shape, facets, and other structural\nDOI: 10.1021/acs.accounts.9b00126 Acc. Chem. Res. 2019, 52, 1507−1518\n1514\nDOI: 10.1021/acs.accounts.9b00126 Acc. Chem. Res. 2019, 52, 1507−1518\n1515\nfeatures of ENMs.48 For instance, we observed that the ability of Pd nanocrystals to generate ROS varied with shape (nanocubes, octahedrons, and concaves) and facets ([100], [111], and [730]) (Figure 8B,C).28,43,45 The discontinuous crystal planes of ENMs create structural defects and thus heterogeneous electronic structures of their surface atoms (e.g., CeO2−ZrO2Nanomaterials, Figure 8D).49 The energy and electronic states of ENMs may change under irradiation with light, such as the antioxidant or pro-oxidant behavior of graphene quantum dots, which is distinct from that without light irradiation (Figure 8E).49 Finally, the stability of ROS and surface redox potential correlate to the pH of the solution, as we observed adjustable ROS generation and Ag ion dissolution of AgNPs under different pH conditions (Figure 8F).11,50"
    }, {
      "heading" : "4. STRATEGIES FOR SAFE NANOMEDICINE DESIGN",
      "text" : "BY MANIPULATING NANO−BIO INTERACTIONS\nControl of the nano−bio interaction is desired in the majority of intelligent nanomedicine designs for medical applications.55 Great efforts have been aimed at understanding the basic mechanisms of nano−bio interactions. The existence of various driving forces and redox reactions at the nano−bio interface can synergistically influence the biological behaviors and fate of nanomedicines. At the same time, these interactions are largely determined by the physiological microenvironment. For example, the concentration of redox reactive species, pH, temperature, and biomolecular physicochemical properties play important roles in determining redox interactions at the nano−bio interface. A comprehensive understanding of the physicochemical properties of ENMs and biomolecules, together with the microenvironmental conditions relevant to nano−bio interactions, will enable us to manipulate key factors so as to rationally design novel nanomedicines. In Table 1, we summarize factors known to date to be related to nano−bio interactions and propose possible strategies for safe nanomedicine design."
    }, {
      "heading" : "5. CONCLUSIONS AND PERSPECTIVES",
      "text" : "ENMs are highly promising agents for medical applications, in which the precise design of clinically safe and effective nanomedicines remains in great need. The biophysicochemical interactions at the nano−bio interface that regulate targeting, drug delivery, diagnostic properties, biocompatibility, and the\npotential toxicity of ENMs are attracting increasing interest worldwide. In this Account, we have summarized the recent achievements in probing the nano−bio interactions of nanomedicines from the perspective of driving forces and redox reactions. Increasing our understanding of the strong and weak noncovalent weak interactions as well as the redox reactions at nano−bio interfaces will elucidate valuable information for the manipulation of the surface chemistryand corona-related driving forces as well as the toxicity derived from dynamic bioidentity and ROS generation of ENM. Furthermore, such knowledge will enable the development of redox active nanomedicines to scavenge or generate intracellular ROS, modify the activities of key oxidoreductases and antioxidants, regulate oxidative stress-related pathways and apoptosis, and mitigate the toxicity of nanomedicines to normal cells and combat bacteria and cancers. Here, we also discussed the factors influencing the nano−bio interaction and propose corresponding strategies to manipulate the nano−bio interactions toward safe-by-design nanomedicine discovery. Although notable progress has been achieved in developing intelligent nanomedicines for combating cancer and bacteria, this burgeoning field is still evolving around many challenges: (1) The surface properties (for example, electronic structure, active sites, distribution, and orientation of surface grafting) of individual nanoparticles are heterogeneous and need to be clearly profiled before application. (2) The quantitative relationships between the physicochemical properties of NPs and function and toxicity are still not fully understood. (3) The advanced technologies and equipment necessary for dynamic, in situ, real time, super high-speed and high-resolution synergetic study of the nano−bio interaction process are still lacking. (4) The combination of various physicochemical factors related to nano−bio interactions results in an enormous number of possibilities in nanomedicine design. Therefore, high-throughput selection and in silico methods, including the nano-quantitative structure−activity relationship (nanoQSAR) method and nanoinformatics, will facilitate the development of nanomedicine through understanding and predicting the basic mechanisms of nano−bio interactions to accelerate the selection of potentially safe and effective formulations. We believe these obstacles will soon be overcome to more comprehensively delineate nano−bio interactions and bring nanomedicine to its next stage.\nDOI: 10.1021/acs.accounts.9b00126 Acc. Chem. Res. 2019, 52, 1507−1518\n1516\n■ AUTHOR INFORMATION Corresponding Author\n*E-mail: chenchy@nanoctr.cn."
    }, {
      "heading" : "ORCID",
      "text" : "Yaling Wang: 0000-0002-5845-5150 Chunying Chen: 0000-0002-6027-0315"
    }, {
      "heading" : "Notes",
      "text" : "The authors declare no competing financial interest."
    }, {
      "heading" : "Biographies",
      "text" : "Yaling Wang received her Ph.D. in Bioinorganic Chemistry at the Institute of High Energy Physics, CAS (2012). She focuses on developing nanomedicine for in vivo imaging, cancer therapy and single cell analysis via nano−bio and synchrotron radiation technologies.\nRong Cai received her Ph.D. in materials science and engineering from the University of Tsukuba and National Center for Materials Science, Japan (2015). She focuses on the understanding of biological effects of nanomaterials and nanosafety for nano−biomedical applications.\nChunying Chen received her Ph.D. in Biomedical Engineering from Huazhong University of Science and Technology of China (1996). Her research interests mainly include nanotoxicology, nanomedicine, nano−bio interfaces, and the transformation and fate of nanomaterials in biological systems.\n■ ACKNOWLEDGMENTS This work was supported by the National Basic Research Plan of China (2016YFA0201600 and 2016YFE0133100), the National Natural Science Foundation of China (31571027, 31700879 and 21675157), the Innovative Research Groups of the National Natural Science Foundation of China (11621505), the CAS Interdisciplinary Innovation Team, the Bureau of International Co-operation Chinese Academy of Sciences (GJHG1852), and the National Science Fund for Distinguished Young Scholars (11425520).\n■ REFERENCES (1) Wilhelm, S.; Tavares, A. J.; Dai, Q.; Ohta, S.; Audet, J.; Dvorak, H. F.; Chan, W. C. Analysis of Nanoparticle Delivery to Tumours. Nat. Rev. Mater. 2016, 1, 16014. (2) Miclaŭs,̧ T.; Beer, C.; Chevallier, J.; Scavenius, C.; Bochenkov, V. E.; Enghild, J. J.; Sutherland, D. S. Dynamic Protein Coronas Revealed as a Modulator of Silver Nanoparticle Sulphidation In Vitro. Nat. Commun. 2016, 7, 11770. (3) Nel, A. E.; Madler, L.; Velegol, D.; Xia, T.; Hoek, E. M.; Somasundaran, P.; Klaessig, F.; Castranova, V.; Thompson, M. Understanding Biophysicochemical Interactions at the Nano-Bio Interface. Nat. Mater. 2009, 8, 543−557. (4) Park, S.; Hamad-Schifferli, K. Nanoscale Interfaces to Biology. Curr. Opin. Chem. Biol. 2010, 14, 616−622. (5) Monopoli, M. P.; Aberg, C.; Salvati, A.; Dawson, K. A. Biomolecular Coronas Provide the Biological Identity of Nanosized Materials. Nat. Nanotechnol. 2012, 7, 779−786. (6) Cai, R.; Chen, C. Protein Corona In Vivo: Dynamic Complement Proteins-Mediated Opsonization and Immune Modulation. Sci. Bull. 2017, 62, 976−977. (7) Walkey, C. D.; Chan, W. C. Understanding and Controlling the Interaction of Nanomaterials with Proteins in a Physiological Environment. Chem. Soc. Rev. 2012, 41, 2780−2799. (8) Wang, X.; Wang, X.; Bai, X.; Yan, L.; Liu, T.; Wang, M.; Song, Y.; Hu, G.; Gu, Z.; Miao, Q.; Chen, C. Nanoparticle Ligand Exchange\nand Its Effects at the Nanoparticle-Cell Membrane Interface. Nano Lett. 2019, 19, 8−18. (9) Chen, R.; Huo, L. L.; Shi, X. F.; Bai, R.; Zhang, Z. J.; Zhao, Y. L.; Chang, Y. Z.; Chen, C. Y. Endoplasmic Reticulum Stress Induced by Zinc Oxide Nanoparticles is an Earlier Biomarker for Nanotoxicological Evaluation. ACS Nano 2014, 8, 2562−2574. (10) Yin, H.; Chen, R.; Casey, P. S.; Ke, P. C.; Davis, T. P.; Chen, C. Reducing the Cytotoxicity of ZnO Nanoparticles by a Pre-formed Protein Corona in a Supplemented Cell Culture Medium. RSC Adv. 2015, 5, 73963−73973. (11) Tian, X.; Jiang, X.; Welch, C.; Croley, T. R.; Wong, T. Y.; Chen, C.; Fan, S.; Chong, Y.; Li, R.; Ge, C.; Chen, C.; Yin, J. J. Bactericidal Effects of Silver Nanoparticles on Lactobacilli and the Underlying Mechanism. ACS Appl. Mater. Interfaces 2018, 10, 8443− 8450. (12) Rodriguez-Quijada, C.; Sanchez-Purra, M.; de Puig, H.; Hamad-Schifferli, K. Physical Properties of Biomolecules at the Nanomaterial Interface. J. Phys. Chem. B 2018, 122, 2827−2840. (13) Ge, C.; Du, J.; Zhao, L.; Wang, L.; Liu, Y.; Li, D.; Yang, Y.; Zhou, R.; Zhao, Y.; Chai, Z.; Chen, C. Binding of Blood Proteins to Carbon Nanotubes Reduces Cytotoxicity. Proc. Natl. Acad. Sci. U. S. A. 2011, 108, 16968−16973. (14) Abraham, A. N.; Sharma, T. K.; Bansal, V.; Shukla, R. Phytochemicals as Dynamic Surface Ligands to Control NanoparticleProtein Interactions. ACS Omega 2018, 3, 2220−2229. (15) Tan, S. F.; Raj, S.; Bisht, G.; Annadata, H. V.; Nijhuis, C. A.; Kral, P.; Mirsaidov, U. Nanoparticle Interactions Guided by ShapeDependent Hydrophobic Forces. Adv. Mater. 2018, 30, No. 1707077. (16) Wang, X.; Wang, M.; Lei, R.; Zhu, S. F.; Zhao, Y.; Chen, C. Chiral Surface of Nanoparticles Determines the Orientation of Adsorbed Transferrin and Its Interaction with Receptors. ACS Nano 2017, 11, 4606−4616. (17) Wang, X.; Wang, X.; Wang, M.; Zhang, D.; Yang, Q.; Liu, T.; Lei, R.; Zhu, S.; Zhao, Y.; Chen, C. Probing Adsorption Behaviors of BSA onto Chiral Surfaces of Nanoparticles. Small 2018, 14, No. 1703982. (18) Hu, K.; Zhou, H.; Liu, Y.; Liu, Z.; Liu, J.; Tang, J.; Li, J.; Zhang, J.; Sheng, W.; Zhao, Y.; Wu, Y.; Chen, C. Hyaluronic Acid Functional Amphipathic and Redox-Responsive Polymer Particles for the CoDelivery of Doxorubicin and Cyclopamine to Eradicate Breast Cancer Cells and Cancer Stem Cells. Nanoscale 2015, 7, 8607−8618. (19) Gu, X.; Zhou, J.; Zhou, L.; Xie, S.; Petti, L.; Wang, S.; Wang, F. Specific Binding of Antigen-Antibody in Physiological Environments: Measurement, Force Characteristics and Analysis. Opt. Laser. Eng. 2018, 104, 252−258. (20) Sun, Y.; Zhao, C.; Gao, N.; Ren, J.; Qu, X. Stereoselective Nanozyme Based on Ceria Nanoparticles Engineered with Amino Acids. Chem. - Eur. J. 2017, 23, 18146−18150. (21) Mirshafiee, V.; Sun, B.; Chang, C. H.; Liao, Y.-P.; Jiang, W.; Jiang, J.; Liu, X.; Wang, X.; Xia, T.; Nel, A. E. Toxicological Profiling of Metal Oxide Nanoparticles in Liver Context Reveals Pyroptosis in Kupffer Cells and Macrophages versus Apoptosis in Hepatocytes. ACS Nano 2018, 12, 3836−3852. (22) Du, J.; Gu, Z.; Yan, L.; Yong, Y.; Yi, X.; Zhang, X.; Liu, J.; Wu, R.; Ge, C.; Chen, C.; Zhao, Y. Poly(Vinylpyrollidone)- and Selenocysteine-Modified Bi2Se3 Nanoparticles Enhance Radiotherapy Efficacy in Tumors and Promote Radioprotection in Normal Tissues. Adv. Mater. 2017, 29, 1701268. (23) Wang, J.; Zhang, L.; Peng, F.; Shi, X.; Leong, D. T. Targeting Endothelial Cell Junctions with Negatively Charged Gold Nanoparticles. Chem. Mater. 2018, 30, 3759−3767. (24) Peng, F.; Setyawati, M. I.; Tee, J. K.; Ding, X.; Wang, J.; Nga, M. E.; Ho, H. K.; Leong, D. T. Nanoparticles Promote In Vivo Breast Cancer Cell Intravasation and Extravasation by Inducing Endothelial Leakiness. Nat. Nanotechnol. 2019, 14, 279−286. (25) Bahrami, A. H.; Weikl, T. R. Curvature-Mediated Assembly of Janus Nanoparticles on Membrane Vesicles. Nano Lett. 2018, 18, 1259−1263.\nDOI: 10.1021/acs.accounts.9b00126 Acc. Chem. Res. 2019, 52, 1507−1518\n1517\n(26) Wang, L.; Li, J.; Pan, J.; Jiang, X.; Ji, Y.; Li, Y.; Qu, Y.; Zhao, Y.; Wu, X.; Chen, C. Revealing the Binding Structure of the Protein Corona on Gold Nanorods Using Synchrotron radiation-Based Techniques: Understanding the Reduced Damage in Cell Membranes. J. Am. Chem. Soc. 2013, 135, 17359−17368. (27) Zheng, X. Y.; Zhao, K.; Tang, J.; Wang, X. Y.; Li, L. D.; Chen, N. X.; Wang, Y. J.; Shi, S.; Zhang, X.; Malaisamy, S.; Sun, L. D.; Wang, X.; Chen, C.; Yan, C. H. Gd-Dots with Strong Ligand-Water Interaction for Ultrasensitive Magnetic Resonance Renography. ACS Nano 2017, 11, 3642−3650. (28) Chong, Y.; Dai, X.; Fang, G.; Wu, R.; Zhao, L.; Ma, X.; Tian, X.; Lee, S.; Zhang, C.; Chen, C.; Chai, Z.; Ge, C.; Zhou, R. Palladium Concave Nanocrystals with High-Index Facets Accelerate Ascorbate Oxidation in Cancer Treatment. Nat. Commun. 2018, 9, 4861. (29) Tsoi, K. M.; MacParland, S. A.; Ma, X.-Z.; Spetzler, V. N.; Echeverri, J.; Ouyang, B.; Fadel, S. M.; Sykes, E. A.; Goldaracena, N.; Kaths, J. M.; Conneely, J. B.; Alman, B. A.; Selzner, M.; Ostrowski, M. A.; Adeyi, O. A.; Zilman, A.; McGilvray, I. D.; Chan, W. C. W. Mechanism of Hard-Nanomaterial Clearance by the Liver. Nat. Mater. 2016, 15, 1212. (30) Yu, M.; Song, W.; Tian, F.; Dai, Z.; Zhu, Q.; Ahmad, E.; Guo, S.; Zhu, C.; Zhong, H.; Yuan, Y.; Zhang, T.; Yi, X.; Shi, X.; Gan, Y.; Gao, H. Temperature- and Rigidity-Mediated Rapid Transport of Lipid Nanovesicles in Hydrogels. Proc. Natl. Acad. Sci. U. S. A. 2019, 116, 5362−5369. (31) Wang, Y.; Qin, Z.; Buehler, M. J.; Xu, Z. Intercalated Water Layers Promote Thermal Dissipation at Bio-Nano Interfaces. Nat. Commun. 2016, 7, 12854. (32) Ezraty, B.; Gennaris, A.; Barras, F.; Collet, J. F. Oxidative Stress, Protein Damage and Repair in Bacteria. Nat. Rev. Microbiol. 2017, 15, 385−396. (33) Catalano, F.; Accomasso, L.; Alberto, G.; Gallina, C.; Raimondo, S.; Geuna, S.; Giachino, C.; Martra, G. Factors Ruling the Uptake of Silica Nanoparticles by Mesenchymal Stem Cells: Agglomeration Versus Dispersions, Absence Versus Presence of Serum Proteins. Small 2015, 11, 2919−2928. (34) Nel, A.; Xia, T.; Mad̈ler, L.; Li, N. Toxic Potential of Materials at the Nanolevel. Science 2006, 311, 622−627. (35) Maiorano, G.; Sabella, S.; Sorce, B.; Brunetti, V.; Malvindi, M. A.; Cingolani, R.; Pompa, P. P. Effects of cell culture media on the dynamic formation of protein-nanoparticle complexes and influence on the cellular response. ACS Nano 2010, 4, 7481−7491. (36) Lao, F.; Chen, L.; Li, W.; Ge, C.; Qu, Y.; Sun, Q.; Zhao, Y.; Han, D.; Chen, C. Fullerene Nanoparticles Selectively Enter Oxidation-Damaged Cerebral Microvessel Endothelial Cells and Inhibit JNK-Related Apoptosis. ACS Nano 2009, 3, 3358−3368. (37) Chong, Y.; Ge, C.; Fang, G.; Wu, R.; Zhang, H.; Chai, Z.; Chen, C.; Yin, J. J. Light-Enhanced Antibacterial Activity of Graphene Oxide, Mainly via Accelerated Electron Transfer. Environ. Sci. Technol. 2017, 51, 10154−10161. (38) Zhou, H.; Zhang, B.; Zheng, J.; Yu, M.; Zhou, T.; Zhao, K.; Jia, Y.; Gao, X.; Chen, C.; Wei, T. The Inhibition of Migration and Invasion of Cancer Cells by Graphene via the Impairment of Mitochondrial Respiration. Biomaterials 2014, 35, 1597−1607. (39) Wang, Z.; Wang, C.; Liu, S.; He, W.; Wang, L.; Gan, J.; Huang, Z.; Wang, Z.; Wei, H.; Zhang, J.; Dong, L. Specifically Formed Corona on Silica Nanoparticles Enhances Transforming Growth Factor β1 Activity in Triggering Lung Fibrosis. ACS Nano 2017, 11, 1659−1672. (40) Zhang, H.; Ji, Z.; Xia, T.; Meng, H.; Low-Kam, C.; Liu, R.; Pokhrel, S.; Lin, S.; Wang, X.; Liao, Y.-P.; Wang, M.; Li, L.; Rallo, R.; Damoiseaux, R.; Telesca, D.; Mad̈ler, L.; Cohen, Y.; Zink, J. I.; Nel, A. E. Use of Metal Oxide Nanoparticle Band Gap To Develop a Predictive Paradigm for Oxidative Stress and Acute Pulmonary Inflammation. ACS Nano 2012, 6, 4349−4368. (41) Burello, E.; Worth, A. P. A Theoretical Framework for Predicting the Oxidative Stress Potential of Oxide Nanoparticles. Nanotoxicology 2011, 5, 228−235.\n(42) Xu, Y.; Schoonen, M. A. A. The Absolute Energy Positions of Conduction and Valence Bands of Selected Semiconducting Minerals. Am. Mineral. 2000, 85, 543−556. (43) Ge, C.; Fang, G.; Shen, X.; Chong, Y.; Wamer, W. G.; Gao, X.; Chai, Z.; Chen, C.; Yin, J. J. Facet Energy versus Enzyme-like Activities: The Unexpected Protection of Palladium Nanocrystals against Oxidative Damage. ACS Nano 2016, 10, 10436−10445. (44) Li, Y. Y.; He, X.; Yin, J. J.; Ma, Y. H.; Zhang, P.; Li, J. Y.; Ding, Y. Y.; Zhang, J.; Zhao, Y. L.; Chai, Z. F.; Zhang, Z. Y. Acquired Superoxide-Scavenging Ability of Ceria Nanoparticles. Angew. Chem., Int. Ed. 2015, 54, 1832−1835. (45) Fang, G.; Li, W.; Shen, X.; Perez-Aguilar, J. M.; Chong, Y.; Gao, X.; Chai, Z.; Chen, C.; Ge, C.; Zhou, R. Differential Pd-nanocrystal facets demonstrate distinct antibacterial activity against Gram-positive and Gram-negative bacteria. Nat. Commun. 2018, 9, 129. (46) Yi, Z.; Ye, J.; Kikugawa, N.; Kako, T.; Ouyang, S.; StuartWilliams, H.; Yang, H.; Cao, J.; Luo, W.; Li, Z.; Liu, Y.; Withers, R. L. An Orthophosphate Semiconductor with Photooxidation Properties under Visible-Light Irradiation. Nat. Mater. 2010, 9, 559−564. (47) Wang, L.; Sun, Q.; Wang, X.; Wen, T.; Yin, J. J.; Wang, P.; Bai, R.; Zhang, X. Q.; Zhang, L. H.; Lu, A. H.; Chen, C. Using Hollow Carbon Nanospheres as a Light-Induced Free Radical Generator to Overcome Chemotherapy Resistance. J. Am. Chem. Soc. 2015, 137, 1947−1955. (48) Auffan, M.; Rose, J.; Bottero, J. Y.; Lowry, G. V.; Jolivet, J. P.; Wiesner, M. R. Towards a Definition of Inorganic Nanoparticles from an Environmental, Health and Safety Perspective. Nat. Nanotechnol. 2009, 4, 634−641. (49) Hartmann, P.; Brezesinski, T.; Sann, J.; Lotnyk, A.; Eufinger, J. P.; Kienle, L.; Janek, J. Defect Chemistry of Oxide Nanomaterials with High Surface Area: Ordered Mesoporous Thin Films of the Oxygen Storage Catalyst CeO2-ZrO2. ACS Nano 2013, 7, 2999−3013. (50) He, W.; Zhou, Y. T.; Wamer, W. G.; Boudreau, M. D.; Yin, J. J. Mechanisms of the pH Dependent Generation of Hydroxyl Radicals and Oxygen Induced by Ag Nanoparticles. Biomaterials 2012, 33, 7547−7555. (51) Plumlee, G. S.; Morman, S. A.; Ziegler, T. L. The Toxicological Geochemistry of Earth Materials: An Overview of Processes and the Interdisciplinary Methods Used to Understand Them. Rev. Mineral. Geochem. 2006, 64, 5−57. (52) Sheng, Y.; Abreu, I. A.; Cabelli, D. E.; Maroney, M. J.; Miller, A. F.; Teixeira, M.; Valentine, J. S. Superoxide Dismutases and Superoxide Reductases. Chem. Rev. 2014, 114, 3854−3918. (53) Koppenol, W. H.; Stanbury, D. M.; Bounds, P. L. Electrode Potentials of Partially Reduced Oxygen Species, from Dioxygen to Water. Free Radical Biol. Med. 2010, 49, 317−322. (54) Chong, Y.; Ge, C.; Fang, G.; Tian, X.; Ma, X.; Wen, T.; Wamer, W. G.; Chen, C.; Chai, Z.; Yin, J. J. Crossover between Anti- and Prooxidant Activities of Graphene Quantum Dots in the Absence or Presence of Light. ACS Nano 2016, 10, 8690−8699. (55) Chen, H.; Gu, Z.; An, H.; Chen, C.; Chen, J.; Cui, R.; Chen, S.; Chen, W.; Chen, X.; Chen, X.; Chen, Z.; Ding, B.; Dong, Q.; Fan, Q.; Fu, T.; Hou, D.; Jiang, Q.; Ke, H.; Jiang, X.; Liu, G.; Li, S.; Li, T.; Liu, Z.; Nie, G.; Ovais, M.; Pang, D.; Qiu, N.; Shen, Y.; Tian, H.; Wang, C.; Wang, H.; Wang, Z.; Xu, H.; Xu, J.-F.; Yang, X.; Zhu, S.; Zheng, X.; Zhang, X.; Zhao, Y.; Tan, W.; Zhang, X.; Zhao, Y. Precise Nanomedicine for Intelligent Therapy of Cancer. Sci. China: Chem. 2018, 61, 1503−1552.\nDOI: 10.1021/acs.accounts.9b00126 Acc. Chem. Res. 2019, 52, 1507−1518\n1518"
    } ],
    "references" : [ {
      "title" : "Nanoscale Interfaces to Biology",
      "author" : [ "S. Park", "K. Hamad-Schifferli" ],
      "venue" : "Curr. Opin. Chem. Biol. 2010,",
      "citeRegEx" : "Park and Hamad.Schifferli,? \\Q2010\\E",
      "shortCiteRegEx" : "Park and Hamad.Schifferli",
      "year" : 2010
    }, {
      "title" : "Physical Properties of Biomolecules at the Nanomaterial Interface",
      "author" : [ "K. Hamad-Schifferli" ],
      "venue" : "J. Phys. Chem. B 2018,",
      "citeRegEx" : "Hamad.Schifferli,? \\Q2018\\E",
      "shortCiteRegEx" : "Hamad.Schifferli",
      "year" : 2018
    }, {
      "title" : "Toxic Potential of Materials at the Nanolevel",
      "author" : [ "A. Nel", "T. Xia", "L. Mad̈ler", "N. Li" ],
      "venue" : "Science",
      "citeRegEx" : "Nel et al\\.,? \\Q2006\\E",
      "shortCiteRegEx" : "Nel et al\\.",
      "year" : 2006
    }, {
      "title" : "Superoxide Dismutases and Superoxide Reductases",
      "author" : [ "M. Teixeira", "J.S. Valentine" ],
      "venue" : "Chem. Rev. 2014,",
      "citeRegEx" : "F. et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "F. et al\\.",
      "year" : 2014
    } ],
    "referenceMentions" : [ ],
    "year" : 2019,
    "abstractText" : "Published as part of the Accounts of Chemical Research special issue “Nanomedicine and Beyond”. Yaling Wang,† Rong Cai,† and Chunying Chen*,†,‡ †CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China ‡University of Chinese Academy of Sciences, Beijing 100049, China",
    "creator" : "PTC Arbortext Advanced Print Publisher 11.1.4300/W Library-x64"
  }
}